Novato, CA, United States of America

Daniel Solomon Gold

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • San Francisco, CA (US) (2016)
  • Novato, CA (US) (2017 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Daniel Solomon Gold: Innovator in Therapeutic Fusion Proteins**

Introduction

Daniel Solomon Gold is a prominent inventor based in Novato, California, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, Gold has focused his research on developing targeted therapeutic agents for lysosomal storage diseases, particularly Mucopolysaccharidosis Type IIIB, also known as Sanfilippo B Syndrome.

Latest Patents

Among Gold's most notable patents is the invention of targeted therapeutic lysosomal enzyme fusion proteins and their applications for treating lysosomal storage diseases. This groundbreaking work involves creating therapeutic fusion proteins that contain a lysosomal enzyme along with a lysosomal targeting moiety, such as an IGF-II peptide, and a spacer peptide. Specifically, his innovations include compositions and methods for treating Sanfilippo B Syndrome through the use of a targeted therapeutic fusion protein comprising alpha-N-acetylglucosaminidase (Naglu), designed to enhance treatment efficacy.

Career Highlights

Gold's career is closely associated with his work at BioMarin Pharmaceutical Inc., a company dedicated to developing innovative biopharmaceuticals for serious diseases and medical conditions. His research efforts have contributed to advancements in the treatment of lysosomal storage disorders, underscoring his role as a key figure in the pharmaceutical industry.

Collaborations

In his professional journey, Daniel Solomon Gold has collaborated with esteemed colleagues, including Mika Aoyagi-Scharber and Teresa Margaret Christianson. These partnerships have facilitated knowledge exchange and fostered innovation, enhancing the development of therapeutic strategies in biotechnology.

Conclusion

Daniel Solomon Gold's relentless pursuit of innovation in therapeutic fusion proteins positions him as a notable inventor in the biotechnology domain. His work not only advances scientific understanding but also offers hope for effective treatments for patients suffering from lysosomal storage diseases. Through his contributions at BioMarin Pharmaceutical Inc. and beyond, Gold continues to make strides in the quest for medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…